Black Rock Inc. Seelos Therapeutics, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $1.64 $1,973 - $20,229	12,335 Added 0.73%	1,693,983 $304,000
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $12,929 - $23,899	19,590 Added 1.18%	1,681,648 $2.02 Million
Q1 2023 May 12, 2023	SELL	$0.59 - $1.04 $73,485 - $129,534	-124,552 Reduced 6.97%	1,662,058 $1.15 Million
Q4 2022 Feb 13, 2023	BUY	$0.66 - $259.46 $6,933 - $2.73 Million	10,506 Added 0.59%	1,786,610 $1.21 Million
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $2,425 - $1.04 Million	-3,731 Reduced 0.21%	1,776,104 $1.83 Million
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $2.3 Million - $4.2 Million	-4,514,132 Reduced 71.72%	1,779,835 $1.21 Million
Q1 2022 May 12, 2022	SELL	$0.84 - $1.71 $226,033 - $460,138	-269,087 Reduced 4.1%	6,293,967 $5.27 Million
Q4 2021 Feb 10, 2022	BUY	$1.59 - $2.38 $286,366 - $428,649	180,105 Added 2.82%	6,563,054 $10.7 Million
Q3 2021 Nov 09, 2021	BUY	$1.69 - $2.89 $1.76 Million - $3.01 Million	1,041,138 Added 19.49%	6,382,949 $15.4 Million
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $14.1 Million - $33.8 Million	5,341,811 New	5,341,811 $14.1 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.